Cargando…

Olfactory dysfunction in patients with primary progressive MS

OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Felix A., Maas, Matthew B., Geran, Rohat, Schmidt, Charlotte, Kunte, Hagen, Ruprecht, Klemens, Paul, Friedemann, Göktas, Önder, Harms, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471346/
https://www.ncbi.nlm.nih.gov/pubmed/28638852
http://dx.doi.org/10.1212/NXI.0000000000000369
_version_ 1783243933168435200
author Schmidt, Felix A.
Maas, Matthew B.
Geran, Rohat
Schmidt, Charlotte
Kunte, Hagen
Ruprecht, Klemens
Paul, Friedemann
Göktas, Önder
Harms, Lutz
author_facet Schmidt, Felix A.
Maas, Matthew B.
Geran, Rohat
Schmidt, Charlotte
Kunte, Hagen
Ruprecht, Klemens
Paul, Friedemann
Göktas, Önder
Harms, Lutz
author_sort Schmidt, Felix A.
collection PubMed
description OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs). Patients with olfactory dysfunction due to an alternative primary etiology were excluded. The validated olfactory testing method yielded individual scores for olfactory threshold, odor discrimination, and odor identification, along with a composite Threshold Discrimination Identification (TDI) score. RESULTS: Olfactory dysfunction was identified in 27 (84%) patients with PPMS, 10 (31%) patients with RRMS, and 1 (3%) HC. While age and sex were similar between PPMS and HCs, the TDI score and all olfactory subscores were significantly worse in patients with PPMS compared with HCs (all p < 0.001). After adjustment for differences in age, sex, Expanded Disability Status Scale (EDSS), and disease duration, odor discrimination, odor identification, and the composite TDI score were worse in patients with PPMS vs RRMS (p = 0.03, 0.04, and 0.02, respectively). Neither age, sex, EDSS, nor disease duration was significantly associated with the composite TDI score. CONCLUSIONS: Olfactory dysfunction was more frequent and severe in PPMS compared with RRMS, independent of disease duration and overall disability status. Further research on cellular level differences in olfactory neural pathways may lead to new insights about disease pathogenesis in MS.
format Online
Article
Text
id pubmed-5471346
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54713462017-06-21 Olfactory dysfunction in patients with primary progressive MS Schmidt, Felix A. Maas, Matthew B. Geran, Rohat Schmidt, Charlotte Kunte, Hagen Ruprecht, Klemens Paul, Friedemann Göktas, Önder Harms, Lutz Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: We tested the hypothesis that olfactory function is more impaired in patients with primary progressive MS (PPMS) than that in relapsing-remitting MS (RRMS). METHODS: Standardized olfactory testing was performed in 32 patients with PPMS, 32 patients with RRMS, and 32 healthy controls (HCs). Patients with olfactory dysfunction due to an alternative primary etiology were excluded. The validated olfactory testing method yielded individual scores for olfactory threshold, odor discrimination, and odor identification, along with a composite Threshold Discrimination Identification (TDI) score. RESULTS: Olfactory dysfunction was identified in 27 (84%) patients with PPMS, 10 (31%) patients with RRMS, and 1 (3%) HC. While age and sex were similar between PPMS and HCs, the TDI score and all olfactory subscores were significantly worse in patients with PPMS compared with HCs (all p < 0.001). After adjustment for differences in age, sex, Expanded Disability Status Scale (EDSS), and disease duration, odor discrimination, odor identification, and the composite TDI score were worse in patients with PPMS vs RRMS (p = 0.03, 0.04, and 0.02, respectively). Neither age, sex, EDSS, nor disease duration was significantly associated with the composite TDI score. CONCLUSIONS: Olfactory dysfunction was more frequent and severe in PPMS compared with RRMS, independent of disease duration and overall disability status. Further research on cellular level differences in olfactory neural pathways may lead to new insights about disease pathogenesis in MS. Lippincott Williams & Wilkins 2017-06-14 /pmc/articles/PMC5471346/ /pubmed/28638852 http://dx.doi.org/10.1212/NXI.0000000000000369 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Schmidt, Felix A.
Maas, Matthew B.
Geran, Rohat
Schmidt, Charlotte
Kunte, Hagen
Ruprecht, Klemens
Paul, Friedemann
Göktas, Önder
Harms, Lutz
Olfactory dysfunction in patients with primary progressive MS
title Olfactory dysfunction in patients with primary progressive MS
title_full Olfactory dysfunction in patients with primary progressive MS
title_fullStr Olfactory dysfunction in patients with primary progressive MS
title_full_unstemmed Olfactory dysfunction in patients with primary progressive MS
title_short Olfactory dysfunction in patients with primary progressive MS
title_sort olfactory dysfunction in patients with primary progressive ms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471346/
https://www.ncbi.nlm.nih.gov/pubmed/28638852
http://dx.doi.org/10.1212/NXI.0000000000000369
work_keys_str_mv AT schmidtfelixa olfactorydysfunctioninpatientswithprimaryprogressivems
AT maasmatthewb olfactorydysfunctioninpatientswithprimaryprogressivems
AT geranrohat olfactorydysfunctioninpatientswithprimaryprogressivems
AT schmidtcharlotte olfactorydysfunctioninpatientswithprimaryprogressivems
AT kuntehagen olfactorydysfunctioninpatientswithprimaryprogressivems
AT ruprechtklemens olfactorydysfunctioninpatientswithprimaryprogressivems
AT paulfriedemann olfactorydysfunctioninpatientswithprimaryprogressivems
AT goktasonder olfactorydysfunctioninpatientswithprimaryprogressivems
AT harmslutz olfactorydysfunctioninpatientswithprimaryprogressivems